Ivacaftor for the treatment of cystic fibrosis in children under six years of age.

Abstract excerpt

Introduction: Cystic fibrosis (CF) results from aberrant ion transport due to abnormalities or absence of the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride transporter that resides on the apical surface of epithelial cells. A novel class of medications, known as CFTR modulators, specifically target the abnormal protein.Areas covered: Ivacaftor increases the open probability of CFTR...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aminophenols
• Share to Child, Preschool
• Share to Cystic Fibrosis